0R2B.LSE Danaher Corp.

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
26.4x
P/B
-
ROE
7.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0R2B.LSE undervalued?

Graham number

The Graham number of Danaher Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Danaher Corp. fundamental analysis

No fundamental analysis for Danaher Corp. yet.

Danaher Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Danaher Corp.

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development…

Full company profile